Beverage for Immune Support

A Phase I/II Clinical Trial in Healthy People Aged 18 Years and Above

NCT05144139 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19)

NCT04352608 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Evaluate the Safety of a Bovine Thymus Nuclear Extract

NCT06795945 ·Status: COMPLETED ·Phase: NA

A Phase 1 Study to Evaluate the Safety of MEDI7814 in Adult Volunteers

NCT01544361 ·Status: COMPLETED ·Phase: PHASE1

Understanding Immunity to the COVID-19 Vaccines

NCT04664309 ·Status: COMPLETED

Safety Tolerability and Pharmacokinetics of Oral NIM-1324 in Healthy Adult Male and Female Volunteers

NCT05019950 ·Status: COMPLETED ·Phase: PHASE1

Phase 1, Single Dose Study to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of MEDI5884

NCT03001297 ·Status: COMPLETED ·Phase: PHASE1

Antigen-specific Cytotoxic T Cells in the Treatment of Opportunistic Infections

NCT03159364 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

A Double-Blind Placebo Controlled Study To Determine the Optimal Immunopharmacological Dose Level of Isoprinosine in Immunodepressed Volunteers

NCT00002059 ·Status: COMPLETED ·Phase: NA

The Safety and Effectiveness of Isoprinosine in Patients With Weakened Immune Systems and Lymph Node Disease

NCT00002296 ·Status: COMPLETED ·Phase: NA

A PhaseⅡ Study to Evaluate the Safety & Immunogenicity of SARS-CoV-2 Alpha/Beta/Delta/Omicron Variants COVID-19 Vaccine

NCT05652543 ·Status: COMPLETED ·Phase: PHASE2

Phase I Clinical Trial of a COVID-19 Vaccine in 18-60 Healthy Adults

NCT04313127 ·Status: COMPLETED ·Phase: PHASE1

Safety Study of Anti-Influenza Virus Monoclonal Antibody to Treat Influenza

NCT01390025 ·Status: COMPLETED ·Phase: PHASE1

A Phase II Clinical Trial to Evaluate the Recombinant Vaccine for COVID-19 (Adenovirus Vector)

NCT04341389 ·Status: COMPLETED ·Phase: PHASE2

Safety and Immunogenicity Study of Booster Vaccination With Medium-dosage or High-dosage SARS-CoV-2 Inactivated Vaccine for Prevention of COVID-19

NCT05079217 ·Status: UNKNOWN ·Phase: PHASE4

A Trial of the Pharmacokinetics, Safety, and Tolerability of Subcutaneous Gamunex® in Primary Immunodeficiency

NCT00389324 ·Status: COMPLETED ·Phase: PHASE2

A Phase 1, Single Dose Study to Evaluate the Safety and Pharmacokinetics of MEDI0382 in Healthy Volunteers

NCT02394314 ·Status: COMPLETED ·Phase: PHASE1

Characterization and Durability of COVID-19 Vaccine Induced Immune Responses in Healthcare/Frontline Workers

NCT05049187 ·Status: COMPLETED

Study to Evaluate the Efficacy and Safety of Ampligen in Patients With Post-COVID Conditions

NCT05592418 ·Status: COMPLETED ·Phase: PHASE2

Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19

NCT04412538 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

The Safety and Immunogenicity of SCTV01C in Healthy Population Aged ≥18 Years Previously Vaccinated With mRNA COVID-19 Vaccine.

NCT05043311 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Phase II / III Study of COVID-19 DNA Vaccine (AG0302-COVID19)

NCT04655625 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Phase 1 Norwalk Vaccine Study

NCT00806962 ·Status: COMPLETED ·Phase: PHASE1

Immunogenicity and Safety of Recombinant COVID-19 Vaccine (CHO Cells)

NCT04813562 ·Status: UNKNOWN ·Phase: PHASE2

A Study of Ad26.COV2.S in Adults (COVID-19)

NCT04436276 ·Status: COMPLETED ·Phase: PHASE1/PHASE2